News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Business
Actavis Names Claudio Albrecht New Chief Executive
June 23, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
DOW JONES NEWSWIRES -- Icelandic generic drug maker Actavis Group (ACT-IC) Wednesday named Claudio Albrecht as new chief executive, succeeding Sigurdur Oli Olafsson, who is stepping down after working for the company for seven years.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Mergers & acquisitions
Merck KGaA Moves Ahead on SpringWorks Buy for $3.9B
April 28, 2025
·
3 min read
·
Tristan Manalac
Layoffs
Caribou Changes Course Again, Lays Off 32% of Workforce
April 25, 2025
·
1 min read
·
Dan Samorodnitsky
Earnings
AbbVie Criticizes Trump’s Drug Pricing Proposal, Deflects Tariff Concerns
April 25, 2025
·
3 min read
·
Annalee Armstrong
Earnings
Gilead’s PrEP Launch Full Speed Ahead Despite Macro Pressures on HIV Space
April 25, 2025
·
3 min read
·
Tristan Manalac